To evaluate GPR15 expression and prognosis in a pan-cancer manner, we used the pre-train multiple variate Cox regression model, which combined specific gene expression value and basic clinical data provided by OncoLnc [46] to identify the TCGA cohorts of which the prognosis is significant with the GPR15 expression value. The gene discussed is GPR15; the disease is cancer.